137 related articles for article (PubMed ID: 16855075)
1. Population pharmacokinetics of amlodipine in hypertensive children and adolescents.
Flynn JT; Nahata MC; Mahan JD; Portman RJ;
J Clin Pharmacol; 2006 Aug; 46(8):905-16. PubMed ID: 16855075
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and antihypertensive profile of amlodipine and felodipine-ER in younger versus older patients with hypertension.
Leenen FH; Coletta E
J Cardiovasc Pharmacol; 2010 Dec; 56(6):669-75. PubMed ID: 20881606
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine; clinical relevance of a unique pharmacokinetic profile.
Meredith PA; Elliott HL
J Cardiovasc Pharmacol; 1993; 22 Suppl A():S6-8. PubMed ID: 7522286
[TBL] [Abstract][Full Text] [Related]
4. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
5. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
Pitsiu M; Hussein Z; Majid O; Aarons L; de Longueville M; Stockis A
Br J Clin Pharmacol; 2004 Apr; 57(4):402-11. PubMed ID: 15025737
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
[TBL] [Abstract][Full Text] [Related]
7. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
8. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
[TBL] [Abstract][Full Text] [Related]
10. Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 years.
Jullien V; Urien S; Hirt D; Delaugerre C; Rey E; Teglas JP; Vaz P; Rouzioux C; Chaix ML; Macassa E; Firtion G; Pons G; Blanche S; Tréluyer JM
Antimicrob Agents Chemother; 2006 Nov; 50(11):3548-55. PubMed ID: 16940058
[TBL] [Abstract][Full Text] [Related]
11. Clonidine disposition in children; a population analysis.
Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.
Mirochnick M; Cooper E; Capparelli E; McIntosh K; Lindsey J; Xu J; Jacobus D; Mofenson L; Bonagura VR; Nachman S; Yogev R; Sullivan JL; Spector SA
Clin Pharmacol Ther; 2001 Jul; 70(1):24-32. PubMed ID: 11452241
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of sumatriptan nasal spray in children.
Christensen ML; Mottern RK; Jabbour JT; Fuseau E
J Clin Pharmacol; 2004 Apr; 44(4):359-67. PubMed ID: 15051742
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of cisapride in neonates.
Odoul F; Le Guellec C; Henrot A; Saliba E; Levron JC; Saux MC; Paintaud G; Autret-Leca E
Eur J Clin Pharmacol; 2002 Nov; 58(8):507-13. PubMed ID: 12451427
[TBL] [Abstract][Full Text] [Related]
16. Population analyses of amlodipine in patients living in the community and patients living in nursing homes.
Kang D; Verotta D; Schwartz JB
Clin Pharmacol Ther; 2006 Jan; 79(1):114-24. PubMed ID: 16413246
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
[TBL] [Abstract][Full Text] [Related]
18. Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis.
Jullien V; Raïs A; Urien S; Dimet J; Delaugerre C; Bouillon-Pichault M; Rey E; Pons G; Blanche S; Tréluyer JM
Br J Clin Pharmacol; 2007 Jul; 64(1):105-9. PubMed ID: 17324223
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension.
Blumer J; Batisky DL; Wells T; Shi V; Solar-Yohay S; Sunkara G
J Clin Pharmacol; 2009 Feb; 49(2):235-41. PubMed ID: 19179299
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of amlodipine besylate at delivery and during lactation.
Morgan JL; Kogutt BK; Meek C; Stehel EK; McIntire DD; Sheffield JS; Roberts SW
Pregnancy Hypertens; 2018 Jan; 11():77-80. PubMed ID: 29523279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
